RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy Meeting Abstract

  

Authors:	Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; Viny, A. D.; Goldberg, A. D.; Tallman, M. S.; Stein, E. M.
Abstract Title:	RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
Meeting Title:	61st Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	134
Issue:	Suppl. 1
Meeting Dates:	2019 Dec 7-10
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2019-11-13
Language:	English
ACCESSION:	WOS:000518218500413
DOI:	10.1182/blood-2019-125319
PROVIDER:	Clarivate Analytics Web of Science
PROVIDER:	wos
Notes:	Meeting Abstract: 18 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/168153